{"id":745014,"date":"2014-03-27T07:20:00","date_gmt":"2014-03-27T07:20:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/"},"modified":"2023-03-22T00:04:57","modified_gmt":"2023-03-22T04:04:57","slug":"merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/","title":{"rendered":"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007"},"content":{"rendered":"<p>\n      Merck (NYSE:MRK), known as MSD outside the United States and Canada,<br \/>\n      today announced the appointment of Robert M. Davis, 47, as executive<br \/>\n      vice president and chief financial officer, effective April 23, 2014.<br \/>\n      Davis, who will also oversee corporate strategy and corporate business<br \/>\n      development, will succeed Peter N. Kellogg, 58. After having made<br \/>\n      significant contributions to the company as Merck\u2019s CFO since 2007,<br \/>\n      Kellogg will work closely with Davis to ensure a seamless transition and<br \/>\n      will leave Merck on May 16.\n    <\/p>\n<p>\n      &#8220;Rob is an accomplished executive with significant financial and<br \/>\n      operational expertise, including as a CFO, and will be an exceptional<br \/>\n      addition to our team,\u201d said Kenneth C. Frazier, chairman and chief<br \/>\n      executive officer, Merck. \u201cRob\u2019s broad, global business and healthcare<br \/>\n      experience, which encompasses commercial, R&#038;D, quality, regulatory,<br \/>\n      manufacturing and supply chain, will be an asset to us in implementing a<br \/>\n      significantly streamlined, more flexible cost structure and operating<br \/>\n      model, while enabling us to focus on our highest-potential growth<br \/>\n      opportunities.\u201d\n    <\/p>\n<p>\n      Davis is corporate vice president and president of Baxter\u2019s Medical<br \/>\n      Products business where he oversaw the successful integration of that<br \/>\n      company\u2019s Global Medication Delivery and Renal businesses, along with<br \/>\n      corporate manufacturing and R&#038;D functions, into a single, integrated<br \/>\n      division, improving R&#038;D productivity and eliminating significant costs.<br \/>\n      Prior to his current role, Davis served as corporate vice president and<br \/>\n      president of Baxter\u2019s Renal business, as corporate vice president and<br \/>\n      chief financial officer from May of 2006 through May of 2010, and as<br \/>\n      treasurer from 2004 through May of 2006. Davis joined Baxter as<br \/>\n      treasurer in 2004 after more than 14 years at Eli Lilly and Company.\n    <\/p>\n<p>\n      &#8220;It is a tremendous opportunity to join Merck at such an exciting time,\u201d<br \/>\n      said Davis. \u201cMerck\u2019s long-standing commitment to science, innovation and<br \/>\n      improving global health is unsurpassed among pharmaceutical companies.\u201d\n    <\/p>\n<p>\n      Kellogg joined Merck in 2007 as executive vice president and chief<br \/>\n      financial officer. He played a major role in driving the execution of<br \/>\n      Merck\u2019s merger with Schering-Plough and in designing the company\u2019s<br \/>\n      capital structure to enhance shareholder returns, including its 2013<br \/>\n      accelerated share repurchase program. To ensure a smooth transition,<br \/>\n      Kellogg will oversee the closing and reporting of the company\u2019s first<br \/>\n      quarter sales and earnings on April 29.\n    <\/p>\n<p>\n      &#8220;Peter has been an important member of the Merck leadership team and<br \/>\n      instrumental in helping to guide Merck during a period of significant<br \/>\n      change at our company and in our industry,\u201d said Frazier. \u201cPeter leaves<br \/>\n      Merck a stronger company, better positioned to deliver long-term value<br \/>\n      to our shareholders.\u201d\n    <\/p>\n<p>\n      &#8220;I am extremely proud of what we have accomplished together during my<br \/>\n      seven year tenure at Merck,\u201d said Kellogg. \u201cAnd while I am excited to<br \/>\n      open another chapter of my professional life, it is heartening that I<br \/>\n      can do so having had the opportunity to contribute to Merck\u2019s legacy and<br \/>\n      long-term success.\u201d\n    <\/p>\n<p>\n      <b>About Merck<\/b>\n    <\/p>\n<p>\n      Today&#8217;s Merck is a global healthcare leader working to help the world be<br \/>\n      well. Merck is known as MSD outside of the United States and Canada.<br \/>\n      Through our prescription medicines, vaccines, biologic therapies, and<br \/>\n      consumer care and animal health products, we work with customers and<br \/>\n      operate in more than 140 countries to deliver innovative health<br \/>\n      solutions. We also demonstrate our commitment to increasing access to<br \/>\n      healthcare through far-reaching policies, programs and partnerships. For<br \/>\n      more information, visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&#038;url=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated&#038;esheet=50832869&#038;newsitemid=20140327005536&#038;lan=en-US&#038;anchor=vip2-msd.com\/merckcom-migrated&#038;index=1&#038;md5=b658c85232ff0e138edac3f0172553ee\" rel=\"nofollow\">vip2-msd.com\/merckcom-migrated<\/a><br \/>\n      and connect with us on <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&#038;url=http%3A%2F%2Fwww.twitter%2FMerck&#038;esheet=50832869&#038;newsitemid=20140327005536&#038;lan=en-US&#038;anchor=Twitter&#038;index=2&#038;md5=69585bc36684d837bba7d87b0d4d4319\" rel=\"nofollow\">Twitter<\/a>,<br \/>\n      <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&#038;url=http%3A%2F%2Fwww.facebook.com%2FMerckBeWell&#038;esheet=50832869&#038;newsitemid=20140327005536&#038;lan=en-US&#038;anchor=Facebook&#038;index=3&#038;md5=bcfa37a99c64001009c093086660e9ac\" rel=\"nofollow\">Facebook<\/a><br \/>\n      and <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&#038;url=http%3A%2F%2Fwww.youtube.com%2FMerck&#038;esheet=50832869&#038;newsitemid=20140327005536&#038;lan=en-US&#038;anchor=YouTube&#038;index=4&#038;md5=2401efb9b9cdf03ea9c8252d802cbba8\" rel=\"nofollow\">YouTube<\/a>.\n    <\/p>\n<p>\n      <b>Forward-Looking Statement<\/b>\n    <\/p>\n<p>\n      This news release includes \u201cforward-looking statements\u201d within the<br \/>\n      meaning of the safe harbor provisions of the United States Private<br \/>\n      Securities Litigation Reform Act of 1995. These statements are based<br \/>\n      upon the current beliefs and expectations of Merck\u2019s management and are<br \/>\n      subject to significant risks and uncertainties. If underlying<br \/>\n      assumptions prove inaccurate or risks or uncertainties materialize,<br \/>\n      actual results may differ materially from those set forth in the<br \/>\n      forward-looking statements.\n    <\/p>\n<p>\n      Risks and uncertainties include but are not limited to, general industry<br \/>\n      conditions and competition; general economic factors, including interest<br \/>\n      rate and currency exchange rate fluctuations; the impact of<br \/>\n      pharmaceutical industry regulation and health care legislation in the<br \/>\n      United States and internationally; global trends toward health care cost<br \/>\n      containment; technological advances, new products and patents attained<br \/>\n      by competitors; challenges inherent in new product development,<br \/>\n      including obtaining regulatory approval; Merck\u2019s ability to accurately<br \/>\n      predict future market conditions; manufacturing difficulties or delays;<br \/>\n      financial instability of international economies and sovereign risk;<br \/>\n      dependence on the effectiveness of Merck patents and other protections<br \/>\n      for innovative products; and the exposure to litigation, including<br \/>\n      patent litigation, and\/or regulatory actions.\n    <\/p>\n<p>\n      Merck undertakes no obligation to publicly update any forward-looking<br \/>\n      statement, whether as a result of new information, future events or<br \/>\n      otherwise. Additional factors that could cause results to differ<br \/>\n      materially from those described in the forward-looking statements can be<br \/>\n      found in Merck\u2019s 2013 Annual Report on Form 10-K and the company\u2019s other<br \/>\n      filings with the Securities and Exchange Commission (SEC) available at<br \/>\n      the SEC\u2019s Internet site (<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&#038;url=http%3A%2F%2Fwww.sec.gov&#038;esheet=50832869&#038;newsitemid=20140327005536&#038;lan=en-US&#038;anchor=www.sec.gov&#038;index=5&#038;md5=e98e5e99ec539883efdd8d20a2c31af5\" rel=\"nofollow\">www.sec.gov<\/a>).\n    <\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&#038;sty=20140327005536r1&#038;sid=hq1sf1&#038;distro=nx\" \/><span class=\"bwct31415\"\/><\/span><\/p>\n<p>       Merck<br \/>Media:<br \/>Steven Cragle, 908-423-3461<br \/>Pam Eisele,        267-305-3558<br \/>or<br \/>Investors:<br \/>Carol Ferguson, 908-423-4465<br \/>Justin        Holko, 908-423-5088     <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the appointment of Robert M. Davis, 47, as executive vice president and chief financial officer, effective April 23, 2014. Davis, who will also oversee corporate strategy and corporate business development, will succeed Peter N. Kellogg, 58. After having made significant contributions to the company as Merck\u2019s CFO since 2007, Kellogg will work closely with Davis to ensure a seamless transition and will leave Merck on May 16. &#8220;Rob is an accomplished executive with significant financial and operational expertise, including as a CFO, and will be an exceptional addition to our team,\u201d said Kenneth C. Frazier, chairman and chief executive officer, Merck. \u201cRob\u2019s broad, global business and healthcare experience, which encompasses commercial, R&#038;D, quality, regulatory, manufacturing and supply chain, will be an asset to us in implementing a significantly streamlined, more flexible cost structure and operating<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[53,64,289],"class_list":["post-745014","news_item","type-news_item","status-publish","hentry","tag-corporate-news","tag-latest-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the appointment of Robert M. Davis, 47, as executive vice president and chief financial officer, effective April 23, 2014. Davis, who will also oversee corporate strategy and corporate business development, will succeed Peter N. Kellogg, 58. After having made significant contributions to the company as Merck\u2019s CFO since 2007, Kellogg will work closely with Davis to ensure a seamless transition and will leave Merck on May 16. &quot;Rob is an accomplished executive with significant financial and operational expertise, including as a CFO, and will be an exceptional addition to our team,\u201d said Kenneth C. Frazier, chairman and chief executive officer, Merck. \u201cRob\u2019s broad, global business and healthcare experience, which encompasses commercial, R&amp;D, quality, regulatory, manufacturing and supply chain, will be an asset to us in implementing a significantly streamlined, more flexible cost structure and operating\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-22T04:04:57+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20140327005536r1&sid=hq1sf1&distro=nx\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\\\/\",\"name\":\"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20140327005536r1&sid=hq1sf1&distro=nx\",\"datePublished\":\"2014-03-27T07:20:00+00:00\",\"dateModified\":\"2023-03-22T04:04:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\\\/#primaryimage\",\"url\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20140327005536r1&sid=hq1sf1&distro=nx\",\"contentUrl\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20140327005536r1&sid=hq1sf1&distro=nx\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/","og_locale":"en_US","og_type":"article","og_title":"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 - Merck.com","og_description":"Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the appointment of Robert M. Davis, 47, as executive vice president and chief financial officer, effective April 23, 2014. Davis, who will also oversee corporate strategy and corporate business development, will succeed Peter N. Kellogg, 58. After having made significant contributions to the company as Merck\u2019s CFO since 2007, Kellogg will work closely with Davis to ensure a seamless transition and will leave Merck on May 16. \"Rob is an accomplished executive with significant financial and operational expertise, including as a CFO, and will be an exceptional addition to our team,\u201d said Kenneth C. Frazier, chairman and chief executive officer, Merck. \u201cRob\u2019s broad, global business and healthcare experience, which encompasses commercial, R&D, quality, regulatory, manufacturing and supply chain, will be an asset to us in implementing a significantly streamlined, more flexible cost structure and operating","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/","og_site_name":"Merck.com","article_modified_time":"2023-03-22T04:04:57+00:00","og_image":[{"url":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20140327005536r1&sid=hq1sf1&distro=nx","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/","name":"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/#primaryimage"},"image":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/#primaryimage"},"thumbnailUrl":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20140327005536r1&sid=hq1sf1&distro=nx","datePublished":"2014-03-27T07:20:00+00:00","dateModified":"2023-03-22T04:04:57+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/#primaryimage","url":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20140327005536r1&sid=hq1sf1&distro=nx","contentUrl":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20140327005536r1&sid=hq1sf1&distro=nx"},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"cc86a86f-9f53-4cb9-8d47-98883eb68bad","news_item_aria_label":"","media_files":null,"document_path":"","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":0,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745014\/revisions"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=745014"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=745014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}